These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8398119)
1. The IGF-II receptor system: a G protein-linked mechanism. Nishimoto I Mol Reprod Dev; 1993 Aug; 35(4):398-406; discussion 406-7. PubMed ID: 8398119 [TBL] [Abstract][Full Text] [Related]
2. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors. Osipo C; Dorman S; Frankfater A Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195 [TBL] [Abstract][Full Text] [Related]
3. Conversion of G-protein specificity of insulin-like growth factor II/mannose 6-phosphate receptor by exchanging of a short region with beta-adrenergic receptor. Takahashi K; Murayama Y; Okamoto T; Yokota T; Ikezu T; Takahashi S; Giambarella U; Ogata E; Nishimoto I Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11772-6. PubMed ID: 8265625 [TBL] [Abstract][Full Text] [Related]
4. Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor. Burstein ES; Spalding TA; Brann MR Biochemistry; 1998 Mar; 37(12):4052-8. PubMed ID: 9521726 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits. Kostenis E; Conklin BR; Wess J Biochemistry; 1997 Feb; 36(6):1487-95. PubMed ID: 9063897 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-II/mannose 6-phosphate receptor is incapable of activating GTP-binding proteins in response to mannose 6-phosphate, but capable in response to insulin-like growth factor-II. Okamoto T; Nishimoto I; Murayama Y; Ohkuni Y; Ogata E Biochem Biophys Res Commun; 1990 May; 168(3):1201-10. PubMed ID: 2161218 [TBL] [Abstract][Full Text] [Related]
7. In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor. Ikezu T; Okamoto T; Giambarella U; Yokota T; Nishimoto I J Biol Chem; 1995 Dec; 270(49):29224-8. PubMed ID: 7493951 [TBL] [Abstract][Full Text] [Related]
8. Reptilian MPR 300 is also the IGF-IIR: cloning, sequencing and functional characterization of the IGF-II binding domain. Sivaramakrishna Y; Amancha PK; Siva Kumar N Int J Biol Macromol; 2009 Jun; 44(5):435-40. PubMed ID: 19428478 [TBL] [Abstract][Full Text] [Related]
9. Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region. Wade SM; Scribner MK; Dalman HM; Taylor JM; Neubig RR Mol Pharmacol; 1996 Aug; 50(2):351-8. PubMed ID: 8700143 [TBL] [Abstract][Full Text] [Related]
10. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Hayashi MK; Haga T Arch Biochem Biophys; 1997 Apr; 340(2):376-82. PubMed ID: 9143344 [TBL] [Abstract][Full Text] [Related]
11. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors. Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106 [TBL] [Abstract][Full Text] [Related]
12. A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity. Grishina G; Berlot CH Mol Pharmacol; 2000 Jun; 57(6):1081-92. PubMed ID: 10825378 [TBL] [Abstract][Full Text] [Related]
13. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Murthy KS; Makhlouf GM Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832 [TBL] [Abstract][Full Text] [Related]
14. The ligand binding site of the formyl peptide receptor maps in the transmembrane region. Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994 [TBL] [Abstract][Full Text] [Related]
15. Molecular determinants in the second intracellular loop of the 5-hydroxytryptamine-1A receptor for G-protein coupling. Kushwaha N; Harwood SC; Wilson AM; Berger M; Tecott LH; Roth BL; Albert PR Mol Pharmacol; 2006 May; 69(5):1518-26. PubMed ID: 16410407 [TBL] [Abstract][Full Text] [Related]
16. [The homology of the primary structure of the third cytoplasmic domains in rhodopsin-type receptors and of the cytoplasmic tail in the beta-subunit of the insulin receptor]. Shpakov AO Tsitologiia; 1996; 38(11):1179-90. PubMed ID: 9082618 [TBL] [Abstract][Full Text] [Related]
18. Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. Chou KC J Proteome Res; 2005; 4(5):1681-6. PubMed ID: 16212421 [TBL] [Abstract][Full Text] [Related]
19. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Bissantz C; Bernard P; Hibert M; Rognan D Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Kristiansen K Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]